Evidence map›Paper›PMID 36497987›Full record

ArticleInternational journal of environmental research and public health2022

Characterization of Gut Microbiota Composition in Type 2 Diabetes Patients: A Population-Based Study.

Isabella Polidori, Laura Marullo, Cristiano Ialongo, Flaminia Tomassetti, Roberto Colombo, Francesca di Gaudio, Graziella Calugi, Giulia Marrone, Annalisa Noce, Sergio Bernardini and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. EnteroaggregativeEcoSal Plus · 2025
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. The Influence of Gut Microbial Species on Diabetes Mellitus.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.Frontiers in cellular and infection microbiology · 2023
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Isabella PolidoriLifebrain srl Cerba Healthcare, Guidonia Montecelio, 190/A Viale Roma, 00012 Rome, Italy.
Laura MarulloLifebrain Nocera Cerba Healthcare, 84014 Nocera Inferiore, Italy.
Cristiano IalongoDepartment of Experimental Medicine, University of Rome "La Sapienza", 00161 Rome, Italy.
Flaminia TomassettiDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-6336-814X
Roberto ColomboLifebrain srl Cerba Healthcare, Guidonia Montecelio, 190/A Viale Roma, 00012 Rome, Italy.
Francesca di GaudioDepartment of Medical Surgery, University of Palermo, 90127 Palermo, Italy.ORCID 0000-0002-5910-5750
Graziella CalugiLifebrain srl Cerba Healthcare, Guidonia Montecelio, 190/A Viale Roma, 00012 Rome, Italy.
Giulia MarroneUOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-5854-2086
Annalisa NoceUOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0003-1310-3730
Sergio BernardiniDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Francesco BroccoloCerba HealthCare Italia, 20137 Milan, Italy.
Massimo PieriDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-3463-0268
University of Rome Tor Vergata · ITSapienza University of Rome · ITUniversity of Milano-Bicocca · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: A clinical laboratory index to assess gut dysbiosis is the F/B ratio < 0.8. In fact, an elevated proportion of Firmicutes and a reduced population of Bacteroides in diabetes type 2 (T2D) subjects has been observed. This study aimed to detail the dysbiosis status in the Italian population, focusing on some pathogenic spectra (T2D) or metabolic disorders. (2) Material and methods: A quantity of 334 fecal samples was analyzed in order to perform genetic testing and sequencing. (3) Results: A trend in over imbalance was observed in the percentage of Proteobacteria (median value: 6.75%; interquartile range (IQR): 3.57−17.29%). A statistically significant association (χ2p = 0.033) was observed between type of dysbiosis and T2D, corresponding to an Odds Ratio (OR) of 1.86. It was noted that females with cystitis/candidiasis are significantly prevalent in T2D patients (p < 0.01; OR: 3.59; 95% CI: 1.43−8.99). Although, in non-diabetic males, a sugar craving is significantly associated with the rate of dysbiosis in non-diabetic males (p < 0.05; OR 1.07; 95% CI 1.00−1.16). (4) Conclusion: In T2D patients, the Bacteroidetes/Firmicutes ratio was biased in favor of Proteobacteria, to be expected due to the nutritional habits of the patients. Thus, T2D females had altered gut permeability favoring the development of infections in the vaginal tract.

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeBacillotaBacteroidesDysbiosisFecesFemaleHumansMaleProteobacteriacandidiasisdiabetesdysbiosismicrobiota

Identifiers

PMID36497987
PMCPMC9740005
OpenAlexW4311040523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.